Europe Genetic Testing Market Share

Statistics for the 2023 & 2024 Europe Genetic Testing market share, created by Mordor Intelligence™ Industry Reports. Europe Genetic Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Genetic Testing Research European DNA Testing Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Europe Genetic Testing Industry

The European Genetic Testing Market is moderately competitive and consists of several major players. Factors such as technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices are expected to drive the market growth. The major players operating in this market include Illumina Inc., Abbott Laboratories, Qiagen, Eurofins Scientific, F. Hoffmann-La Roche Ltd, and 23andMe Inc., among others.

Europe Genetic Testing Market Leaders

  1. Abbott Laboratories

  2. Illumina Inc.

  3. 23andMe Inc.

  4. Qiagen

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

gene.png

Europe Genetic Testing Market Report Snapshots

Europe Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)